Last year for us, like all Ukrainians, was a daily test for stability and loyalty to a common idea. We each received a unique experience of restructuring processes and organizing…
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…